Orthopaedic Surgery, EarlyView.Between 2002 and 2022, the volume of joint arthroplasties among patients with rheumatoid arthritis increased significantly, indicating a growing surgical demand over time. Concurrently, preoperative medication strategies shifted from glucocorticoid‐dominant therapy toward wider use of csDMARDs and bDMARDs/tsDMARDs.
Xingshan Wang +7 more
wiley +1 more source
OA14 The effect of biologic disease-modifying antirheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patients [PDF]
Martin Lauran +6 more
openalex +1 more source
Effects of disease‐modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: Comment on the article by Haynes et al [PDF]
, 2008 Anca I. Catrina, Lars Klareskog
openalex +1 more source
AB0277 PREVALENCE OF HEPATITIS MARKERS IN PATIENTS TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: RESULTS OF THE TUNISIAN REGISTRY BINAR [PDF]
, 2020 A. Fazaa +17 more
openalex +1 more source
Periodontitis and rheumatoid arthritis—Global efforts to untangle two complex diseases
Periodontology 2000, EarlyView.Abstract Understanding the impact of oral health on rheumatoid arthritis (RA) will inform how best to manage patients with both periodontitis and RA. This review seeks to provide an update on interventional and mechanistic investigations, including a brief summary of European Research programs investigating the link between periodontitis and RA. Recent
Isabel Lopez‐Oliva +2 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 3, Page 733-737, March 2026.ABSTRACT Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome is caused by pathogenic variants in the GATA3 gene located on chromosome 10p14. Here we present a 10‐year‐old girl with HDR syndrome who also has oligoarticular juvenile idiopathic arthritis (JIA).
Lauren N. Meiss +8 more
wiley +1 more source
Aphthous colitis induced by non-steroidal antirheumatic drugs
Swiss Medical Weekly, 2003 I Zuber-Jerger
doaj +1 more source
JAK-Inhibitors – A Story of Success and Adverse Events
Open Access Rheumatology: Research and ReviewsRebekka Wlassits,1 Mathias Müller,2 Karl H Fenzl,1 Thomas Lamprecht,3 Ludwig Erlacher3 1Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, Austria; 2Department für Biomedizinische Wissenschaften, Institut für Tierzucht und ...
Wlassits R +4 more
doaj
Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized controlled trial [PDF]
, 2018 Zhanguo Li +9 more
openalex +1 more source
Recent Therapeutics Policies of Arthritis Rheumatoid (Part I) [PDF]
, 2018 Therapy in RA has undergone many advances today and in line with knowledge of the pathogenesis of RA, the current therapeutic goal is to alter the journey and control the activity of RA disease.
Andisari, H. E. (Hendrata)
core